HELEN’S SUCCESS STORY: HOW NEUROTHERAPY HELPED REVERSE COGNITIVE DECLINE AND RECLAIM MULTITASKING (Podcast Episode 11)
by Heather Putney, PHD, LMFT, CSAT-S, QEEG-DL
EXECUTIVE DIRECTOR, FOUNDER
Untethered Therapy and Transformative Neurotherapy
Helen’s journey began with a familiar tension we see often in our clinic: a family history of Alzheimer’s, a gradual slip in multitasking, and that uneasy feeling that something is off—even when standard labs say everything’s fine. What gave her an edge was a baseline brain scan we had taken when she was feeling well. Months later, after the chaos of the holidays, she noticed a sharp drop in mental agility. A follow-up scan gave us a clear comparison. Her brain patterns looked disorganized, with underperforming regions that weren’t getting the support they needed. Instead of guessing, we used objective data to guide a targeted plan. That’s the heart of modern neurotherapy: measure function, map deficits, stimulate with precision, and retest to validate change.
We focused on two fronts: direct brain support and root-cause investigation. On the brain side, Helen used a cap-based system with LEDs and stimulation tools aimed at regions showing low activity and poor efficiency. Our goal was to increase regional blood flow, improve network timing, and reinforce healthier oscillations. On the root-cause side, we started with posture and perfusion. A chiropractic evaluation revealed spinal misalignment that could impair blood flow to the brain. Correcting it helped improve delivery of oxygen and nutrients. We also ran comprehensive blood tests to rule out metabolic issues, mineral imbalances, and vitamin deficits. The work didn’t stop at symptoms—it traced upstream signals that might be holding her brain back.
One unexpected clue stood out: Helen had recently started a statin. While statins are essential for many, they can, in some individuals, influence lipid availability that brain cells rely on for membrane integrity, myelination, and synaptic function. With her physician’s guidance, she tapered off the statin and monitored changes alongside her neurotherapy sessions. This wasn’t a one-variable experiment—it was a structured sequence of interventions with ongoing scanning. The scans told a visual story: chaotic lines settling into more orderly rhythms as her sleep improved, focus returned, and daily tasks felt easier. For Helen, those before-and-after images reinforced a powerful truth: brain change is visible, measurable, and trainable.
The results unfolded in phases. Sleep quality improved within a few sessions—a foundational win, since deep sleep helps consolidate memories, clear metabolic waste, and recalibrate neural networks. Next came focus: fewer stalls in the kitchen, smoother task switching, and renewed confidence with grandkid logistics. Multitasking returned not as frantic juggling but as calm sequencing—a sign that her networks were coordinating more efficiently. We performed periodic rescans every twenty-plus sessions to create feedback loops, allowing us to shift attention to areas still lagging. This iterative approach makes neurotherapy feel less like a one-time fix and more like an evolving training plan guided by evidence.
For skeptics, Helen’s experience offers a practical bridge: it’s easier to trust what you can see. Brain maps and progress scans reduce uncertainty and anchor subjective improvements to objective change. But the most important lesson is methodological. Don’t stop at treating outputs—investigate inputs. Check alignment that may affect blood flow. Review medications for unintended cognitive effects. Confirm micronutrient status. Then pair all of that with targeted brain stimulation to rebuild efficiency where it’s lacking. The synergy of root-cause care and neurotherapy turns vague complaints into a solvable roadmap.
Helen’s story highlights a hopeful truth we’ve seen again and again: with the right data and a tailored plan, the brain can reorganize, resilience can return, and everyday life can feel possible again.